Intensity Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.10

+0.07 (+1.61%)

As of Jun 30, 10:47 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +802.4% upside

Low Target $31.85

Average Target $37.00

High Target $43.82

Current Price $4.10

Current
$4.10

Target
$37.00

$31.85 $37.00 avg $43.82

Scenario Analysis

Bear Case

$31.85

676.8%

Low target

Base Case

$37.00

+802.4%

Avg target

Bull Case

$43.82

+968.8%

High target

Risk/Reward

1.4x

Balanced

Price in Context

52-Week High

$43.50

-90.6% from high

52-Week Low

$3.51

+16.8% from low

Target vs 52W High

$37.00

-14.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%